William Blair Investment Management LLC Raises Holdings in Integer Holdings Corporation $ITGR

William Blair Investment Management LLC lifted its holdings in shares of Integer Holdings Corporation (NYSE:ITGR) by 70.1% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 468,377 shares of the medical equipment provider’s stock after acquiring an additional 192,956 shares during the period. William Blair Investment Management LLC’s holdings in Integer were worth $36,735,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of ITGR. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Integer by 4.0% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,515 shares of the medical equipment provider’s stock worth $2,539,000 after acquiring an additional 837 shares during the last quarter. Millennium Management LLC grew its stake in shares of Integer by 2,408.8% during the first quarter. Millennium Management LLC now owns 123,132 shares of the medical equipment provider’s stock worth $14,531,000 after acquiring an additional 118,224 shares during the last quarter. Jones Financial Companies Lllp grew its stake in shares of Integer by 79,888.9% during the first quarter. Jones Financial Companies Lllp now owns 7,199 shares of the medical equipment provider’s stock worth $850,000 after acquiring an additional 7,190 shares during the last quarter. United Services Automobile Association purchased a new stake in shares of Integer during the first quarter worth about $258,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of Integer by 4.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 109,316 shares of the medical equipment provider’s stock worth $12,900,000 after acquiring an additional 4,873 shares during the last quarter. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Integer Trading Up 0.1%

Integer stock opened at $89.34 on Monday. The company has a current ratio of 3.75, a quick ratio of 2.38 and a debt-to-equity ratio of 0.77. Integer Holdings Corporation has a 12 month low of $62.00 and a 12 month high of $123.78. The stock’s 50 day simple moving average is $86.78 and its two-hundred day simple moving average is $81.86. The firm has a market cap of $3.03 billion, a PE ratio of 22.28, a P/E/G ratio of 2.10 and a beta of 0.67.

Integer (NYSE:ITGR) last released its quarterly earnings data on Thursday, April 30th. The medical equipment provider reported $1.20 EPS for the quarter, missing the consensus estimate of $1.21 by ($0.01). Integer had a return on equity of 12.83% and a net margin of 7.64%.The company had revenue of $439.58 million during the quarter, compared to analysts’ expectations of $426.48 million. During the same quarter in the prior year, the company posted $1.31 EPS. The company’s revenue for the quarter was up .5% on a year-over-year basis. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. Analysts anticipate that Integer Holdings Corporation will post 6.04 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the company. Wells Fargo & Company upped their target price on Integer from $72.00 to $84.00 and gave the company an “equal weight” rating in a research report on Friday, February 20th. Truist Financial upped their target price on Integer from $95.00 to $97.00 and gave the company a “buy” rating in a research report on Friday, February 20th. Citigroup dropped their target price on Integer from $92.00 to $89.00 and set a “neutral” rating on the stock in a research report on Friday, May 1st. Piper Sandler reiterated an “overweight” rating and issued a $97.00 target price (up from $87.00) on shares of Integer in a research report on Friday, May 1st. Finally, Raymond James Financial reiterated an “outperform” rating and issued a $101.00 target price on shares of Integer in a research report on Monday, February 23rd. Four research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $98.29.

Key Integer News

Here are the key news stories impacting Integer this week:

• Negative Sentiment: Zacks Research lowered its FY2026 earnings estimate for Integer to $6.05 per share from $6.40, signaling softer profit expectations for the medical equipment maker.
• Negative Sentiment: The firm also trimmed near-term estimates for Q3 2026, Q1 2027, Q2 2027, and FY2028, reinforcing concerns that earnings growth may be more uneven than previously expected.
• Negative Sentiment: A Globe and Mail item titled “Integer Holdings Earnings Call Flags Tough 2026” suggests the company’s latest commentary pointed to a difficult operating year ahead, which may be pressuring sentiment. Article Title

Insider Buying and Selling

In other Integer news, VP Tommy P. Thomas sold 825 shares of the company’s stock in a transaction that occurred on Friday, March 13th. The stock was sold at an average price of $85.00, for a total value of $70,125.00. Following the sale, the vice president owned 4,381 shares in the company, valued at approximately $372,385. This represents a 15.85% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 1.10% of the company’s stock.

Integer Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.